Skip to content

Azzly ® - Behavioral Health Practice Management Software

FacebookLinkedinX-twitterYoutubeSpotifyInstagram

Who We Serve
Features
Pricing Plans
Expert Services
- Software Implementation Plan
- Integrated Billing
Resources
(772) 567-0206

Who We Serve
Features
Pricing Plans
Expert Services
- Software Implementation Plan
- Integrated Billing
Resources
(772) 567-0206

Who We Serve
Features
Pricing Plans
Expert Services
- Software Implementation Plan
- Integrated Billing
Resources
(772) 567-0206

Who We Serve
Features
Pricing Plans
Expert Services
- Software Implementation Plan
- Integrated Billing
Resources
(772) 567-0206

Tag: johnson and johnson

Funding

$26 Billion Oxycontin Settlement Will Fund Drug Treatment Services in 14 States

14 states have agreed to a $26 billion settlement with

February 4, 2022 No Comments

AZZLY®: Behavioral Health EHR & EMR Software

Orlando, FL/Vero Beach, FL

1 (888) 400-3201

Useful Links

Programs We Serve
Software
Pricing Plan
Expert Services
Resources
The Team
Login
Contact

Who We Serve

Mental Health
Community-Based Outpatient
Inpatient Psychiatric Rehabilitation
Residential Treatment
Medication Management
Eating Disorder
Addiction Treatment
Medication Assisted Treatment
Abstinence-Based Treatment
Detox Inpatient-Outpatient
Office-Based Opioid Treatment (OBOT)
RCM Healthcare Services

Solutions

EMR/EHR
Outcome Measurement Tools
Billing/RCM
Analytics
Mobility
Learning Services
Patient Engagement
Consulting
Telehealth

LinkedinFacebookX-twitterInstagramYoutubeSpotify

American Owned & Operated. © Copyright 2025 AZZLY. All rights reserved | Powered by Visionation

| Home | Sitemap | Privacy Policy | Services Agreement | 1 (888) 400-3201 | Orlando, FL/Vero Beach, FL

Scroll to Top

Related Pages:

lindsay johnson

Understanding the $26 Billion Oxycontin Settlement

Recently, Johnson and Johnson reached a $26 billion settlement related to the sale of Oxycontin, a highly addictive opioid painkiller. This settlement will fund drug treatment services in 14 states, providing much-needed resources for individuals struggling with addiction.

As a consultant in the healthcare industry, it is important to stay informed about legal settlements and their implications for patient care. This landmark agreement will not only hold pharmaceutical companies accountable for their role in the opioid crisis, but also provide support for those in need of treatment services.

Related Pages:

lindsay johnson

Understanding the $26 Billion Oxycontin Settlement

Recently, Johnson and Johnson reached a $26 billion settlement related to the sale of Oxycontin, a highly addictive opioid painkiller. This settlement will fund drug treatment services in 14 states, providing much-needed resources for individuals struggling with addiction.

As a consultant in the healthcare industry, it is important to stay informed about legal settlements and their implications for patient care. This landmark agreement will not only hold pharmaceutical companies accountable for their role in the opioid crisis, but also provide support for those in need of treatment services.